Products & Services
3-2,4-dimethoxybenzylidene-anabaseine
(4-Methoxyphenyl) Methyl (6R,7R)-3-(Chloromethyl)-8-Oxo-7-(2-Phenylacetamido)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylate
(4-Methoxyphenyl) Methyl (6R,7R)-3-(Chloromethyl)-8-Oxo-7-(2-Phenylacetamido)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylate
Aripiprazole
Aripiprazole
Aripiprazole Monohydrate
Carteolol
CARTEOLOL
Carteolol HCl
Carteolol HCl
CDHP
Cilostazol
Cilostazol (Micronized)
Commercial Bulk Plant of Second Tokushima Factory in To
Commercial Bulk Plant of Second Tokushima Factory in To
Commercial Bulk Plant of Second Tokushima Factory in Tokushima, Japan
Commercial Bulk Plant of Second Tokushima Factory in Tokushima, Japan
Difamilast
Diindolylmethane
Diindolylmethane Drug Substance
Facilities and Operating Procedures at the Saga Factory
Facilities and Operating Procedures at the Saga Factory
Facilities and Operating Procedures at the Saga Factory, Japan
Facilities and Operating Procedures at the Saga Factory, Japan
Formulation Research Institute in Tokushima Japan
Formulation Research Institute in Tokushima, Japan
Ftorafur (also called Futraful or Tegafur)
GCLE Intermediate For Cephalosporin
GCLE Intermediate For Cephalosporin
Gimerasil
GTS-21
Iodipamide
Iodipamide Drug Substance
Iohexol
IoHexol Drug Substance For Oral Products
Ipd-1151t Drug Substance
Lipoprotein Lipase Activator
Lipoprotein Lipase Activator
Manufacturing Site Facilities Personnel and General
Manufacturing Site, Facilities, Personnel, and General
Manufacturing Site Facilities Personnel and General Operating Procedures in Tokushima Japan
Manufacturing Site Facilities Personnel and General Operating Procedures in Tokushima Japan
Nadifloxacin
Nadifloxacin
Nadifloxacin Drug Substance
Nadifloxacin Drug Substance
No 1886 Drug Substance
No-1886 Drug Substance
OPA 15406 DRUG SUBSTANCE
Oranekishijin Hydrochloride Hydrate
p-methoxybenzyl(6r,7r)-3-chloromethyl-8-oxo-7-phenylacetamido-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxylate, gcle
p-methoxybenzyl(6R,7R)-3-chloromethyl-8-oxo-7-phenylacetamido-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, gcle
P-methoxybenzyl (6R,7R)-3-chloromethyl-8-oxo-7-phenylacetamido-5-thia-1-azabicyclo 4.2.0 oct-2-ene-2-carboxylate gcle chemical substance
P-methoxybenzyl (6R,7R)-3-chloromethyl-8-oxo-7-phenylacetamido-5-thia-1-azabicyclo 4.2.0 oct-2-ene-2-carboxylate gcle chemical substance
Procaterol
Procaterol
Procaterol Aerosol Formulation Produced in Tokushima Factory
Procaterol Aerosol Formulation Produced in Tokushima Factory
Procaterol Hydrochloride Hemihydrate
Procaterol Hydrochloride Hemihydrate
Rebamipide
Rebamipide
Rebamipide
Rebamipide (OPC-12759) Drug Substance
Rebamipide (OPC-12759) Drug Substance
Sterile Water for Injection USP 2 mL Vial
Sterile Water for Injection USP 2 mL Vial
Suplatast Tosilate
TAC 101
TAC-101 Drug Substance
Tas-103
Tazobactam
Tazobactam
Tazobactam Otsuka
Tazobactam Otsuka
Tazobactam Sodium
Tazobactam Sodium
Tegafur
Tipiracil Hydrochloride
Tipiracil hydrochloride (TPI)
Tolvaptan
Country
Japan
Otsuka Pharmaceutical (Tolvaptan Spray Dried Powder Manufacturer)@Otsuka Pharmaceutical (Tolvaptan Manufacturer)
Country
Japan
City
Tokushima
Tolvaptan
Country
Japan
Otsuka Pharmaceutical (Tolvaptan Spray Dried Powder Manufacturer)@Otsuka Pharmaceutical (Tolvaptan Manufacturer)
Country
Japan
City
Tokushima